N-arachidonoyl glycine suppresses Na+ / Ca2+ exchanger-mediated Ca2+ entry into endothelial cells and activates BKCa channels independently of GPCRs

British Journal of Pharmacology

Volumn 169, Issue 4, 2013, Pages 933-948

  Bondarenko, Alexander I ^a,b   Drachuk, Konstantin ^b   Panasiuk, Olga ^b   Sagach, Vadim ^b   Deak, Andras T ^a   Malli, Roland ^a   Graier, Wolfgang F ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b BOGOMOLETZ INSTITUTE OF PHYSIOLOGY   (Ukraine)

Author keywords

acetylcholine; BKCa channels; endothelial; histamine; membrane potential; N arachidonoyl glycine; Na+ Ca2+ exchanger

Indexed keywords

2 [2 [4 (4 NITROBENZYLOXY)PHENYL]ETHYL]ISOTHIOUREA METHANESULFONATE; AMINO ACID DERIVATIVE; ANANDAMIDE; BEPRIDIL; CALCIUM ACTIVATED POTASSIUM CHANNEL; CALCIUM ION; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; G PROTEIN COUPLED RECEPTOR; GUANOSINE 5' O (2 THIODIPHOSPHATE); HISTAMINE; N ARACHIDONOYL GLYCINE; PAXILLINE; SODIUM CALCIUM EXCHANGE PROTEIN; SODIUM ION; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD VESSEL REACTIVITY; CALCIUM TRANSPORT; CONTROLLED STUDY; DIALYSIS; DRUG MECHANISM; ELECTROPHYSIOLOGY; HUMAN; HUMAN CELL; HYPERPOLARIZATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR TISSUE;

ANIMALS; AORTA; ARACHIDONIC ACIDS; CALCIUM CHANNEL BLOCKERS; CALCIUM SIGNALING; CELL LINE; CELL MEMBRANE; CELL-FREE SYSTEM; ENDOTHELIUM, VASCULAR; GLYCINE; HISTAMINE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; MALE; MEMBRANE POTENTIALS; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, WISTAR; RECEPTORS, G-PROTEIN-COUPLED; SODIUM-CALCIUM EXCHANGER; VASOCONSTRICTION; VASODILATOR AGENTS;

EID: 84878338494     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12180     Document Type: Article

References (62)

1. Abdullaev IF, Bisaillon JM, Potier M, Gonzalez JC, Motiani RK, Trebak M, (2008). Stim1 and Orai1 mediate CRAC currents and store-operated calcium entry important for endothelial cell proliferation. Circ Res 103: 1289-1299.
2. Alexander SP, (2012). So what do we call GPR18 now? Br J Pharmacol 165: 2411-2413.
3. Alexander SPH, Mathie A, Peter JA, (2011). Guide to Receptors and Channels (GRAC), 5th edition. Br J Pharmacol 164 (Suppl. S1): S1-S324.
4. Barana A, Amoros I, Caballero R, Gomez R, Osuna L, Lillo MP, et al. (2010). Endocannabinoids and cannabinoid analogues block cardiac hKv1.5 channels in a cannabinoid receptor-independent manner. Cardiovasc Res 85: 56-67.
5. Barbara G, Alloui A, Nargeot J, Lory P, Eschalier A, Bourinet E, et al. (2009). T-type calcium channel inhibition underlies the analgesic effects of the endogenous lipoamino acids. J Neurosci 29: 13106-13114.
6. Beech DJ, (2009). Harmony and discord in endothelial calcium entry. Circ Res 104: e22-e23.
7. Begg M, Pacher P, Batkai S, Osei-Hyiaman D, Offertaler L, Mo FM, et al. (2005). Evidence for novel cannabinoid receptors. Pharmacol Ther 106: 133-145.
8. 2+ extrusion in ATP-stimulated endothelium of intact rat aorta. Biochem Biophys Res Commun 395: 126-130.
9. Berra-Romani R, Raqeeb A, Torres-Jacome J, Guzman-Silva A, Guerra G, Tanzi F, et al. (2012). The mechanism of injury-induced intracellular calcium concentration oscillations in the endothelium of excised rat aorta. J Vasc Res 49: 65-76.
10. Bondarenko A, (2004). Sodium-calcium exchanger contributes to membrane hyperpolarization of intact endothelial cells from rat aorta during acetylcholine stimulation. Br J Pharmacol 143: 9-18.
11. Bondarenko A, Chesler M, (2001). Rapid astrocyte death induced by transient hypoxia, acidosis, and extracellular ion shifts. Glia 34: 134-142.
12. Bondarenko A, Sagach V, (2006). Na+-K+-ATPase is involved in the sustained ACh-induced hyperpolarization of endothelial cells from rat aorta. Br J Pharmacol 149: 958-965.
13. 2+ exchange in hypoxia-related acute astrocyte death. Glia 49: 143-152.
14. Bondarenko A, Waldeck-Weiermair M, Naghdi S, Poteser M, Malli R, Graier WF, (2010). GPR55-dependent and -independent ion signalling in response to lysophosphatidylinositol in endothelial cells. Br J Pharmacol 161: 308-320.
15. Bondarenko AI, Sagach VF, (1996). Modulation of the membrane potential of intact guinea pig aortic endothelium. Neurophysiology 28: 202-207.
16. + channels in endothelial cells. Pflugers Arch 461: 177-189.
17. + channels. Pflugers Arch 462: 245-255.
18. Bradshaw HB, Rimmerman N, Hu SS, Benton VM, Stuart JM, Masuda K, et al. (2009). The endocannabinoid anandamide is a precursor for the signaling lipid N-arachidonoyl glycine by two distinct pathways. BMC Biochem 10: 14.
19. Burstein S, McQuain C, Ross A, Salmonsen R, Zurier RE, (2011). Resolution of inflammation by N-arachidonoylglycine. J Cell Biochem 112: 3227-3233.
20. Crowley JJ, Treistman SN, Dopico AM, (2003). Cholesterol antagonizes ethanol potentiation of human brain BKCa channels reconstituted into phospholipid bilayers. Mol Pharmacol 64: 365-372.
21. 2+ entry by abrogating STIM1/Orai1 interaction. J Cell Sci 126: 879-888.
22. Edgell CJ, McDonald CC, Graham JB, (1983). Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Natl Acad Sci U S A 80: 3734-3737.
23. Girardin NC, Antigny F, Frieden M, (2010). Electrophysiological characterization of store-operated and agonist-induced Ca2+ entry pathways in endothelial cells. Pflugers Arch 460: 109-120.
24. Herradon E, Martin MI, Lopez-Miranda V, (2007). Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta. Br J Pharmacol 152: 699-708.
25. Ho WS, Randall MD, (2007). Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol. Br J Pharmacol 150: 641-651.
26. Huang SM, Bisogno T, Petros TJ, Chang SY, Zavitsanos PA, Zipkin RE, et al. (2001). Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain. J Biol Chem 276: 42639-42644.
27. Jarai Z, Wagner JA, Varga K, Lake KD, Compton DR, Martin BR, et al. (1999). Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proc Natl Acad Sci U S A 96: 14136-14141.
28. Jeong HJ, Vandenberg RJ, Vaughan CW, (2010). N-arachidonyl-glycine modulates synaptic transmission in superficial dorsal horn. Br J Pharmacol 161: 925-935.
29. 2+ store depletion in endothelial cells. Cell Calcium 43: 83-94.
30. Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG, (2010). NC3Rs Reporting Guidelines Working Group. Br J Pharmacol 160: 1577-1579.
31. Kohno M, Hasegawa H, Inoue A, Muraoka M, Miyazaki T, Oka K, et al. (2006). Identification of N-arachidonylglycine as the endogenous ligand for orphan G-protein-coupled receptor GPR18. Biochem Biophys Res Commun 347: 827-832.
32. Kuszczak I, Samson SE, Pande J, Shen DQ, Grover AK, (2011). Sodium-calcium exchanger and lipid rafts in pig coronary artery smooth muscle. Biochim Biophys Acta 1808: 589-596.
33. 2+ release and entry during contraction elicited by norepinephrine in rat resistance arteries. Am J Physiol 276 (1 Pt 2): H300-H308.
34. 2+ exchange inhibitors in attenuating ischemia-reperfusion injury. Can J Cardiol 21: 509-516.
35. Lu VB, Puhl HL, 3rd, Ikeda SR, (2013). N-Arachidonyl glycine does not activate G protein-coupled receptor 18 signaling via canonical pathways. Mol Pharmacol 83: 267-282.
36. McCollum L, Howlett AC, Mukhopadhyay S, (2007). Anandamide-mediated CB1/CB2 cannabinoid receptor-independent nitric oxide production in rabbit aortic endothelial cells. J Pharmacol Exp Ther 321: 930-937.
37. McGrath J, Drummond G, McLachlan E, Kilkenny C, Wainwright C, (2010). Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160: 1573-1576.
38. McHugh D, (2012). GPR18 in Microglia: implications for the CNS and endocannabinoid system signalling. Br J Pharmacol 167: 1575-1582. doi: 10.1111/j.1476-5381.2012.02019.x.
39. McHugh D, Hu SS, Rimmerman N, Juknat A, Vogel Z, Walker JM, et al. (2010). N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor. BMC Neurosci 11: 44.
40. McHugh D, Page J, Dunn E, Bradshaw HB, (2012). Delta(9) -THC and N-arachidonyl glycine are full agonists at GPR18 and cause migration in the human endometrial cell line, HEC-1B. Br J Pharmacol 165: 2414-2424. doi: 10.1111/j.1476-5381.2011.01497.x.
41. + entry, and Ca2+ store refilling. J Biol Chem 278: 44769-44779.
42. Marchenko SM, Sage SO, (1993). Electrical properties of resting and acetylcholine-stimulated endothelium in intact rat aorta. J Physiol 462: 735-751.
43. Milman G, Maor Y, Abu-Lafi S, Horowitz M, Gallily R, Batkai S, et al. (2006). N-arachidonoyl L-serine, an endocannabinoid-like brain constituent with vasodilatory properties. Proc Natl Acad Sci U S A 103: 2428-2433.
44. Mukhopadhyay S, Chapnick BM, Howlett AC, (2002). Anandamide-induced vasorelaxation in rabbit aortic rings has two components: G protein dependent and independent. Am J Physiol Heart Circ Physiol 282: H2046-H2054.
45. Naghdi S, Waldeck-Weiermair M, Fertschai I, Poteser M, Graier WF, Malli R, (2010). Mitochondrial Ca2+ uptake and not mitochondrial motility is required for STIM1-Orai1-dependent store-operated Ca2+ entry. J Cell Sci 123 (Pt 15): 2553-2564.
46. Nilius B, Droogmans G, (2001). Ion channels and their functional role in vascular endothelium. Physiol Rev 81: 1415-1459.
47. O'Sullivan SE, Kendall DA, Randall MD, (2005). Vascular effects of delta 9-tetrahydrocannabinol (THC), anandamide and N-arachidonoyldopamine (NADA) in the rat isolated aorta. Eur J Pharmacol 507: 211-221.
48. Offertaler L, Mo FM, Batkai S, Liu J, Begg M, Razdan RK, et al. (2003). Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor. Mol Pharmacol 63: 699-705.
49. Oh DY, Yoon JM, Moon MJ, Hwang JI, Choe H, Lee JY, et al. (2008). Identification of farnesyl pyrophosphate and N-arachidonylglycine as endogenous ligands for GPR92. J Biol Chem 283: 21054-21064.
50. Oz M, (2006). Receptor-independent actions of cannabinoids on cell membranes: focus on endocannabinoids. Pharmacol Ther 111: 114-144.
51. 2+-ATPase. J Physiol 524 (Pt 3): 701-713.
52. Parmar N, Ho WS, (2010). N-arachidonoyl glycine, an endogenous lipid that acts as a vasorelaxant via nitric oxide and large conductance calcium-activated potassium channels. Br J Pharmacol 160: 594-603.
53. Ross HR, Gilmore AJ, Connor M, (2009). Inhibition of human recombinant T-type calcium channels by the endocannabinoid N-arachidonoyl dopamine. Br J Pharmacol 156: 740-750.
54. Sandow SL, Grayson TH, (2009). Limits of isolation and culture: intact vascular endothelium and BKCa. Am J Physiol Heart Circ Physiol 297: H1-H7.
55. 2+ exchanger in endothelial NO production and endothelium-dependent relaxation. Am J Physiol Heart Circ Physiol 283: H837-H844.
56. Sheskin T, Hanus L, Slager J, Vogel Z, Mechoulam R, (1997). Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor. J Med Chem 40: 659-667.
57. Takenouchi R, Inoue K, Kambe Y, Miyata A, (2012). N-arachidonoyl glycine induces macrophage apoptosis via GPR18. Biochem Biophys Res Commun 418: 366-371.
58. Tsumura M, Sobhan U, Muramatsu T, Sato M, Ichikawa H, Sahara Y, et al. (2012). TRPV1-mediated calcium signal couples with cannabinoid receptors and sodium-calcium exchangers in rat odontoblasts. Cell Calcium 52: 124-136.
59. Vuong LA, Mitchell VA, Vaughan CW, (2008). Actions of N-arachidonyl-glycine in a rat neuropathic pain model. Neuropharmacology 54: 189-193.
60. Wagner JA, Varga K, Jarai Z, Kunos G, (1999). Mesenteric vasodilation mediated by endothelial anandamide receptors. Hypertension 33 (1 Pt 2): 429-434.
61. Yin H, Chu A, Li W, Wang B, Shelton F, Otero F, et al. (2009). Lipid G protein-coupled receptor ligand identification using beta-arrestin PathHunter assay. J Biol Chem 284: 12328-12338.
62. 2+ channel current and lowers blood pressure. Am J Physiol Heart Circ Physiol 298: H1472-H1483.